We verified this hypothesis through in vitro functional studies by assessing the effect of TRIB2 overexpression in two GC cell lines (MKN45 and NCI-N87) characterized by a CIN phenotype and an “intermediate” endogenous expression of the protein. The gene discussed is TRIB2; the disease is gastric cancer.